AKIN, M. Et Al. 2018. Effectiveness and safety of sofosbuvir/ledipasvir +/- ribavirin treatment in liver and/or renal transplant patients with chronic hepatitis C: A single-center experience. SAGE OPEN MEDICINE , vol.6 .

AKIN, M., Buldukoglu, O. Ç., ADANIR, H., SÜLEYMANLAR, İ., DİNÇER, D., & YILDIRIM, B., (2018). Effectiveness and safety of sofosbuvir/ledipasvir +/- ribavirin treatment in liver and/or renal transplant patients with chronic hepatitis C: A single-center experience. SAGE OPEN MEDICINE , vol.6.

AKIN, METE Et Al. "Effectiveness and safety of sofosbuvir/ledipasvir +/- ribavirin treatment in liver and/or renal transplant patients with chronic hepatitis C: A single-center experience," SAGE OPEN MEDICINE , vol.6, 2018

AKIN, METE Et Al. "Effectiveness and safety of sofosbuvir/ledipasvir +/- ribavirin treatment in liver and/or renal transplant patients with chronic hepatitis C: A single-center experience." SAGE OPEN MEDICINE , vol.6, 2018

AKIN, M. Et Al. (2018) . "Effectiveness and safety of sofosbuvir/ledipasvir +/- ribavirin treatment in liver and/or renal transplant patients with chronic hepatitis C: A single-center experience." SAGE OPEN MEDICINE , vol.6.

@article{article, author={METE AKIN Et Al. }, title={Effectiveness and safety of sofosbuvir/ledipasvir +/- ribavirin treatment in liver and/or renal transplant patients with chronic hepatitis C: A single-center experience}, journal={SAGE OPEN MEDICINE}, year=2018}